Patient stories about cancer drugs
Help beat cancer sooner
Our life-saving work relies on the money you give us.
Donate now and together we can save more lives by beating cancer sooner.
Stories from patients about cancer drugs
Helping more people survive cancer is the aim of everything we do. Read stories from people who have benefited from cancer drugs, and how research has made a difference to them.
Finding the right treatment
Alfred from London was diagnosed with advanced prostate cancer in 2012. He took part in the Cancer Research UK trial STAMPEDE, which is trying to find the best treatment for people with prostate cancer. For his part in the trial he was given abiraterone, which Cancer Research UK scientists developed. "When I found out I was eligible, I thought: ‘There’s something I can do’. Not just for myself, but for others too."
Sophie was diagnosed with cervical cancer in February 2017 and was treated with radiotherapy and a drug called cisplatin, which Cancer Research UK scientists had a leading role in developing. She hadn’t been to a cervical screening appointment (‘smear test’) for about ten years and wants to encourage women who don’t take part to find out more about having the test and how any abnormal changes can be treated, stopping the disease before it starts. She lives in Huddersfield with her husband Elliott and their daughter Effie Rose. "The test only takes five minutes but it could save your life. I’ve been encouraging all my female friends to attend their smear tests and two of them have now had abnormal changes found."
Testing a new combination
Tommy from Liverpool was diagnosed with bladder cancer just before his 60th birthday, and took part in the TUXEDO clinical trial. The trial was testing a drug that Cancer Research UK scientists helped discover called cextuximab, alongside chemotherapy and radiotherapy. He remembers, “I decided I’d do it in about 10 seconds.” Since the trial Tommy has had two clear scans and a clear biopsy. “I knew nothing about trials before this, but I couldn’t ask for more – everyone’s been great. They’re keeping a close eye on me.”
The FOXTROT trial
Alan from Kidderminster was diagnosed with bowel cancer in 2008. He took part in the FOXTROT clinical trial, which used a drug called panitumumab. Cancer Research UK scientists' cancer biology research led to the development of panitumumab. “I think the trial definitely helped me. Having chemotherapy before my operation helped shrink my tumour which made it easier for the surgeon to remove.”